Upadacitinib as monotherapy and in combination with non-biologic disease-modifying antirheumatic drugs for psoriatic arthritis.

Saved in:
Bibliographic Details
Title: Upadacitinib as monotherapy and in combination with non-biologic disease-modifying antirheumatic drugs for psoriatic arthritis.
Authors: Nash, Peter1 drpnash@tpg.com.au, Richette, Pascal2,3, Gossec, Laure4,5, Marchesoni, Antonio6, Ritchlin, Christopher7, Kato, Koji8, McDearmon-Blondell, Erin L8, Lesser, Elizabeth8, McCaskill, Reva8, Feng, Dai8, Anderson, Jaclyn K8, Ruderman, Eric M9
Source: Rheumatology. Aug2022, Vol. 61 Issue 8, p3257-3268. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14620324
DOI:10.1093/rheumatology/keab905